The new oral anticoagulants

被引:0
作者
F. W. A. Verheugt
机构
[1] Onze Lieve Vrouwe Gasthuis,Department of Cardiology
来源
Netherlands Heart Journal | 2010年 / 18卷
关键词
Anticoagulants, Administration, Oral; Atrial Fibrillation; Warfarin; Drug Discovery; Stroke;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:314 / 318
页数:4
相关论文
共 64 条
[1]  
Wolf PA(1987)Atrial fibrillation: a major contributor to stroke. The Framingham study Arch Intern Med 147 1561-74
[2]  
Abbott RD(1987)The natural history of lone atrial fibrillation: A population-based study over three decades N Engl J Med 317 669-5
[3]  
Kannel WB(2002)Antithrombotic therapy for atrial fibrillation BMJ. 325 1022-70
[4]  
Kopecky SL(2001)Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2864-913
[5]  
Gersh BJ(2007)Anticoagulants in heart disease: current status and perspectives Eur Heart J 28 880-13
[6]  
McGoon MD(2002)Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial Lancet 360 109-74
[7]  
Lip GY(2002)Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 969-502
[8]  
Hart RG(2002)Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 136 161-17
[9]  
Conway DS(2001)Effect of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494-8
[10]  
Gage BF(2006)Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 1706-1